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Abstract
 
Although immunoglobulin (Ig)M
 
hi
 
IgD
 
lo/
 
2
 
CD21
 
hi
 
 marginal zone B cells represent a significant
proportion of naive peripheral splenic B lymphocytes, few of the genes that regulate their de-
velopment have been identified. This subset of peripheral B cells fails to emerge in mice that
 
lack nuclear factor (NF)-
 
k
 
Bp50. Less drastic reductions in marginal zone B cell numbers are
also seen in the spleens of recombination activating gene (Rag)-2
 
2
 
/
 
2
 
 mice reconstituted with
NF-
 
k
 
Bp65
 
2
 
/
 
2
 
 fetal liver cells and in c-Rel
 
2
 
/
 
2
 
 mice. In contrast, steady-state levels of IgD
 
hi
 
splenic follicular B cells are not significantly reduced in the absence of NF-
 
k
 
Bp50, NF-
 
k
 
Bp65,
or c-Rel. Reconstitution of B cells in Rag-2
 
2
 
/
 
2
 
 mice with a mixture of p50
 
2
 
/
 
2
 
/p65
 
2
 
/
 
2
 
 fetal
liver cells and Rag-2
 
2
 
/
 
2
 
 bone marrow cells revealed that the generation of marginal zone B
cells requires the expression of NF-
 
k
 
B in developing B cells, as opposed to supporting cells.
Key words: transcription factors • lymphocyte development • recombination activating gene-
2
 
2
 
/
 
2
 
 mice • peripheral B cells • Bruton’s tyrosine kinase
 
Introduction
 
A distinct population of splenic IgM
 
hi
 
IgD
 
lo
 
CD21
 
hi
 
CD1
 
hi
 
peripheral B lymphocytes known as marginal zone (MZ)
 
1
 
B cells resides close to the marginal sinus (1–6). Other B
cells, including some memory cells, also reside in MZs but
can be distinguished from MZ B cells. MZ B cells are large
lymphocytes, have a distinct morphology (3), and make up
 
z
 
1/10 of the naive B cells in the spleen. These cells ex-
press high levels of B7-1 and B7-2 and may differentiate
into plasma cells in a matter of hours when triggered in
vitro by bacterial LPS, anti-CD40, or IL-4 (4). MZ B cells
do not divide or differentiate in response to antigen recep-
tor ligation, and proliferate far more avidly than follicular B
cells in response to LPS. They may represent specialized
lymphocytes that are particularly efficient APCs, and which
can be induced to rapidly secrete antibodies directed against
subsets of environmental antigens (4).
Very little is understood about the signals and pathways
involved in the development of MZ B cells. MZ B cells fail
to develop in the absence of CD19 (5, 6), but these cells
develop normally in mice that lack T cells (4, 5), in LPS-
nonresponsive mice, and in mice maintained in germ-free
conditions (5). Mice that lack the Pyk2 tyrosine kinase
have recently been demonstrated to lack MZ B cells (7).
The only transcriptional regulator that has been linked to
MZ B cell development is the Aiolos zinc finger protein
(8), but, as discussed below, this nuclear protein is not di-
rectly required for MZ B cell development. It is known
that MZ B cells respond particularly well to LPS (3), and
that B cells from nuclear factor (NF)-
 
k
 
Bp50
 
2
 
/
 
2
 
 mice re-
spond poorly to LPS (9). Therefore, we wished to deter-
mine if NF-
 
k
 
B proteins are required for MZ B cell genera-
tion. We show here that NF-
 
k
 
Bp50 is required for MZ B
cell generation, and that NF-
 
k
 
Bp65/RelA and c-Rel play
significant but less critical roles in this process. We show
that NF-
 
k
 
B must be expressed in lymphocytes in order for
B lineage cells to develop into MZ B cells. We hypothesize
that NF-
 
k
 
Bp50–containing complexes must be activated in
maturing peripheral B cells to induce these cells to acquire
a MZ phenotype.
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Materials and Methods
 
Mice.
 
p50
 
2
 
/
 
2
 
 (9), p65
 
1
 
/
 
2
 
 (10), and c-Rel
 
2
 
/
 
2
 
 mice (11, 12)
were used in these studies. Mice were analyzed between 8 and 12
wk after birth. All animal studies were approved by institutional
review boards.
 
Reconstitution of the Lymphoid Compartment in Rag-2
 
2
 
/
 
2
 
 Mice.
 
Reconstitutions of NF-
 
k
 
B
 
2
 
/
 
2
 
 fetal liver cells into recombination
activating gene (Rag)-2
 
2
 
/
 
2
 
 mice were performed as described in
Horwitz et al. (13). Rag-2
 
2
 
/
 
2
 
 mice were obtained from Taconic.
 
Flow Cytometric Analysis.
 
Flow cytometry was performed es-
sentially as described previously (14). Single cell suspensions were
made from the spleen. 10
 
6
 
 cells were incubated with 2.4 G2
(anti-CD16/CD32 [Fc
 
g
 
 III/II receptor], rat IgG
 
2b
 
, 
 
k
 
, culture su-
pernatant), before staining with the following antibodies: anti-
CD21/CD35–FITC clone 7G6, anti-CD1d–FITC clone 1B1,
anti-CD38–FITC clone 90, anti-TNP–biotin clone A19-3, anti-
IgM–PE clone R6-60, anti-CD23–PE clone B3B4, anti-
CD45R–PE/Cy7 clone RA3-6B2 (all from BD PharMingen),
and anti-IgD–biotin clone 11-26 (Southern Biotechnology Asso-
ciates, Inc.). Biotinylated antibodies were revealed using strepta-
vidin-allophycocyanin.
Viable lymphoid cells were identified by forward and side scat-
ter and 30,000 events were collected. IgM
 
hi
 
IgD
 
lo
 
 cells were ana-
lyzed for the expression of CD21. Flow cytometric analysis was
performed on an Epics Elite ESP flow cytometer (Coulter)
equipped with an ultraviolet-enhanced argon ion blue laser and a
helium/neon red laser. In general, negative controls were used to
set voltage and single color positive controls were used for elec-
tronic compensation. Processed samples were analyzed using Ep-
ics Elite analysis software and FloJo v3.0.5 (Tree Star Corp).
 
In Vivo Capture of TNP-Ficoll by MZ B Lymphocytes.
 
In addi-
tion to immunophenotyping approaches, MZ B cells were also
revealed by a functional assay involving the in vivo capture of in-
travenously injected TNP-Ficoll (7). 100 
 
m
 
g of TNP-Ficoll (pro-
vided by Drs. Rodolphe Guinamard and Jeffrey Ravetch, The
Rockefeller University, New York, NY) was injected. 30 min af-
ter injection, mice were killed and splenocytes were stained with
antibodies against IgM, IgD, and TNP, or with antibodies against
B220/CD45R, CD23, CD21, and TNP.
 
Immunofluorescence Staining of Tissue Sections.
 
Immunofluores-
cence staining was performed essentially according to the method
of Oliver et al. (4), with minor modifications. Spleens were har-
vested and immediately frozen in OCT compound (Miles). 5-
 
m
 
m-
thick sections were cut and stored at 
 
2
 
80
 
8
 
C until use. All sub-
sequent manipulations were done at room temperature. Sections
were air dried for 15 min, fixed in ice-cold acetone for 10 min,
air dried briefly, blocked with 5% normal horse serum for 20
min, and stained with MOMA-1 (rat IgG2a, tissue culture super-
natant; Serotec) for 1 h. Sections were then stained with a 1:200
dilution of biotin–SP-goat anti–rat IgG (H
 
1
 
L) (Jackson Im-
munoresearch Laboratories) for 1 h and streptavidin-PE (2 
 
m
 
g/
ml; BD PharMingen) for 30 min. The sections were then
blocked with 5% normal rat serum for 10 min and stained with
anti-IgM–FITC clone R6-60.2 (10 
 
m
 
g/ml; BD PharMingen).
Sections were rinsed in PBS (five times, 3 min each) between
stainings but not after the blocking steps. The sections were
mounted in a polyvinyl alcohol–based aqueous medium contain-
ing 
 
N
 
-propyl gallate (5 mg/ml) and viewed with an Axioplan 2
fluorescence microscope (ZEISS) equipped with appropriate fil-
ters. Images were acquired with a Sensys cooled CCD camera
(Photometrics Ltd.) and a Power Macintosh computer, and pro-
cessed using Openlab software v2.0.9 (Improvision) and Adobe
Photoshop
 
®
 
 v5.0.2.
 
Results and Discussion
 
A major defect seen in resting B cells from p50
 
2
 
/
 
2
 
 mice
is their inability to proliferate in response to LPS (9, 15).
Intriguingly, LPS induces the proliferation of MZ B cells
far more readily than it does follicular B cells (4), and this
difference may be 
 
z
 
10–15-fold at some doses. To deter-
mine whether NF-
 
k
 
Bp50 was required for MZ B cell de-
velopment, we analyzed splenic B lymphoid cells in NF-
 
k
 
Bp50
 
2
 
/
 
2
 
 mice. Upon examination of frozen sections of
splenic tissue stained with anti-IgM and MOMA-1 (which
stains MZ metallophilic macrophages) we were unable to
detect B cells beyond the follicular rim defined by
MOMA-1, indicating that the MZ B cell population was
markedly reduced (Fig. 1 a). More quantitative estimates of
MZ B cell and follicular B cell numbers can be made by
flow cytometry. As shown in Fig. 1 b, the proportions of B
cells in the IgD
 
hi
 
IgM
 
lo
 
 and IgM
 
hi
 
IgD
 
hi
 
 follicular B cell pop-
ulations were similar in mutant and wild-type mice. The
IgM
 
hi
 
IgD
 
lo
 
 population (which is largely made up of newly
formed B cells and MZ B cells) in p50
 
2
 
/
 
2
 
 mice was ana-
lyzed in terms of CD21 expression, and a marked reduction
was noted in CD21
 
hi
 
 MZ B cells (Fig. 1 c). Similar marked
reductions in MZ B cell numbers in p50
 
2
 
/
 
2
 
 mice were
noted using two other markers for this population, CD1d
and CD38 (Fig. 1 d).
We used a functional assay for the detection of MZ B
cells based on the ability of these cells to capture T cell–
independent type II antigens. It has been shown that TNP-
Ficoll injected intravenously decorates MZ B lymphocytes
but not follicular B cells (7). The in vivo capture of a T
cell–independent type II antigen by MZ B cells does not
occur efficiently in mice that lack CD21 or C3 (7), sug-
gesting that complement-coated T cell–independent
type II antigens bind to MZ B cells in vivo. As seen in
Fig. 2, TNP-Ficoll can be seen in association with
B220
 
1
 
CD21
 
hi
 
CD23
 
lo
 
 MZ B cells isolated from wild-type
spleens. Very few cells that capture TNP-Ficoll were seen
in the B220
 
1
 
CD21
 
hi
 
CD23
 
lo
 
 population from p50
 
2
 
/
 
2
 
spleens. Newly formed B cells (B220
 
1
 
CD23
 
lo
 
CD21
 
lo
 
) and
follicular B cells (B220
 
1
 
CD23
 
hi
 
CD21
 
int
 
) from p50
 
2
 
/
 
2
 
spleens also failed to capture TNP-Ficoll, confirming that
the development of MZ B cells is significantly impaired in
the absence of p50. Experiments performed in parallel with
antibodies to IgM, IgD, and TNP confirmed that p50
 
2
 
/
 
2
 
spleens lack detectable numbers of B cells that associate
with intravenously injected TNP-Ficoll (data not shown).
Because p50 forms complexes in B cells with both p65/
RelA and c-Rel, we examined MZ B cells in Rag-2
 
2
 
/
 
2
 
mice reconstituted with fetal liver cells lacking p65, and in
c-Rel
 
2
 
/
 
2
 
 mice. In the absence of p65, mice die during em-
bryogenesis. To examine the role of this NF-kB protein in
lymphocyte development, Rag-22/2 mice were irradiated
and reconstituted with mixtures of p652/2 fetal liver cells
and Rag-22/2 bone marrow cells. As seen in Fig. 3 a, al-
though splenic follicular B cells are well reconstituted in
the absence of p65, MZ B cells are nevertheless reduced to
z1/3 their normal numbers. A similar observation can be1177 Cariappa et al.
made in the absence of c-Rel (Fig. 3 b). We conclude that
although the requirement for p65 or for c-Rel is not as
stringent as the requirement for p50, complexes containing
p65 or c-Rel contribute to MZ B cell development.
Given that signals from neighboring cells may induce the
differentiation of precursor B cells into MZ-type cells, we
wished to establish whether NF-kBp50 is required in lym-
phocytes themselves, as opposed to being required in sup-
Figure 1. NF-kBp50 is required for MZ B cell generation. (a) Immunofluorescence performed on splenic cryosections with anti-IgM–FITC and
MOMA-1–PE revealed a marked reduction in MZ B cells in the p502/2 mouse (right). Multiple sections revealed similar results. WT, wild-type. (b)
Splenic IgMhiIgDhi and IgDhiIgMlo follicular B cell populations appear grossly normal in the p502/2 mouse. (c) IgMhiIgDloCD21hi MZ B cells are mark-
edly reduced in p502/2 mice. Three wild-type and three p502/2 mice were analyzed in the above studies. The results shown are representative. (d)
IgMhiIgDloCD1dhi and IgMhiIgDloCD38hi MZ B cells are markedly reduced in p502/2 mice. Three wild-type and three p502/2 mice were analyzed in
the above studies. The results shown are representative.1178 A Nuclear Factor Required for Marginal Zone B Cell Development
porting cells such as macrophages or other nonlymphoid
cells. For instance, defects in MZ formation and the re-
duced numbers of peripheral B cells seen in the absence of
NF-kBp52 are believed to reflect a requirement for this
protein in accessory cells (16). In the combined absence of
both p50 and p65, lymphopoiesis is blocked but can be res-
cued by wild-type hematopoietic cells, which suggests that
this defect is not cell autonomous (13). To address whether
NF-kB is required in lymphocytes or in supporting cells for
MZ B cell generation, Rag-22/2 mice were lethally irradi-
ated and reconstituted with mixtures containing equal
numbers of NF-kB–deficient fetal liver cells and Rag-2–
deficient bone marrow cells as described (13, 17). As seen
in the top panel of Fig. 4, splenic B cells were reconstituted
in Rag-22/2 recipients that received fetal liver cells from
mice lacking both p50 and p65 in conjunction with Rag-
22/2 bone marrow. Similar reconstitution experiments
were performed using p502/2 fetal liver cells (data not
shown). Mature follicular IgMhiIgDhi and IgDhiIgMlo frac-
tions were well reconstituted in the absence of both p50
and p65. Examination of the IgMhiIgDlo/2 fraction revealed
the near total lack of CD21hi MZ B cells in the absence of
Figure 2. A T cell–independent type II antigen
is captured in vivo by wild-type (WT) MZ B cells
but not by any of the B cell populations in p502/2
spleens. Splenocytes were isolated from wild-
type and p502/2 mice that were or were not im-
munized with TNP-Ficoll. In immunized mice,
cells that could be stained with anti-TNP anti-
bodies were readily visualized within the
CD45R1CD21hiCD23lo MZ B cell gate. Signifi-
cant numbers of TNP-staining cells were not seen
in any of the splenic B cell pools in p502/2 mice.1179 Cariappa et al.
p50 and p65 (Fig. 4, bottom panel). These results clearly
established that NF-kB is required within lymphoid cells
for MZ B cells to be generated.
NF-kB and IkB proteins are critical for several events
during B cell development, although it is clear that in this
context NF-kB has both cell-autonomous and non–cell-
autonomous functions (for a review, see reference 18). NF-
kBp50 and c-Rel are required for lymphocyte survival and
proliferation, and p50, p65, and c-Rel also participate in
isotype switching in activated B lymphocytes (10–13, 15,
17–21). The proliferative responses of B lymphocytes are
significantly impaired in mice that lack c-Rel (11, 12), and
these B cells fail to induce the Bcl-2 family member A1 af-
ter antigen receptor ligation (21).
In Xid mice, Bruton’s tyrosine kinase (Btk)2/2 mice, and
CD452/2 mice (see reference 22 for further references on
these mutants), absolute numbers of IgDhiIgMlo B cells are
markedly diminished, and this is apparent in flow cytomet-
ric profiles. These cells represent the most mature subpopu-
lation of naive follicular B cells, and their loss in the absence
of Btk reflects ongoing apoptosis (14). In addition to the ap-
optotic loss of IgDhiIgMlo/2 follicular B cells, Xid and Btk2/2
mice also have defects in antigen receptor–mediated pro-
liferation, but MZ B cells are readily identified in these mice
(5, 23). The defect in antigen receptor–induced prolifera-
tion in the absence of Btk has been tied to the failure to ac-
tivate NF-kB (24, 25). This defect may be distinct from the
apoptotic loss of IgDhiIgMlo/2 B cells noted in the absence
of Btk, as steady-state levels of these follicular B cells are not
significantly diminished in the absence of p50 (9, 11, 12;
Figs. 1–3, and Fig. 5 a). Although p50 may contribute to the
maintenance of follicular B cells (20), this contribution can-
not account for the far more obvious steady-state loss of fol-
licular B cells seen in the absence of Btk. Although the ab-
solute numbers of follicular B cells are not reduced in the
absence of p50 or c-Rel (follicular B cell numbers are actu-
ally enhanced in the absence of c-Rel; Fig. 5 a), these pro-
teins as well as p65 are required for MZ B cell generation.
p50 appears to be stringently required for the generation of
MZ B cells, whereas p65 and c-Rel appear to make impor-
Figure 3. NF-kBp65 and c-Rel contribute to MZ B cell development. (a) IgMhiIgDloCD21hi MZ B cells are markedly reduced in Rag-22/2 mice re-
constituted with p652/2 fetal liver and Rag-22/2 bone marrow cells (bottom panels). Splenic IgDhiIgMlo follicular B cell numbers appear grossly normal
(top panels). Two p652/2 chimeras were analyzed in these studies. The results shown are representative. WT, wild-type. (b) IgMhiIgDloCD21hi MZ B
cells are markedly reduced in c-Rel2/2 mice (bottom panels), but splenic IgDhiIgMlo follicular B cell numbers appear grossly normal (top panels). Two
control and two c-Rel2/2 mice were analyzed. The results shown are representative.1180 A Nuclear Factor Required for Marginal Zone B Cell Development
tant but lesser contributions to the development of this B
cell subpopulation. Quantitative comparisons of the abso-
lute numbers of newly formed, follicular and MZ B cells in
wild-type and mutant mice are depicted in Fig. 5, a and b. It
is possible that p50/p65 and p50/c-Rel complexes contrib-
ute in roughly equal measure to the transcriptional events
required for the acquisition of the MZ B cell phenotype.
We have demonstrated that NF-kB is required in lym-
phocytes during the development of MZ B cells. It is likely
that a cell surface receptor on B lymphocytes must signal to
activate NF-kBp50–containing complexes in order for ma-
ture B cells to acquire the MZ phenotype. NF-kBp50 is
essential for the survival/differentiation of MZ B cells but is
apparently not critical for the development of naive follicu-
lar B cells. Whether NF-kB is involved in the differentia-
tion of MZ B cell precursors or is required for the survival
of MZ B cells is unclear.
MZ B cells fail to develop in the absence of CD19 (5, 6),
suggesting that the B cell receptor (BCR) may be required
for MZ B cell generation. However, although BCR signal-
ing is enhanced in the absence of Aiolos, Aiolos2/2 mice
lack MZ B cells (8), suggesting that a direct relationship
might not exist between the strength of BCR signaling and
MZ B cell generation. We have recently shown that
Aiolos2/2/Xid double mutants have normal numbers of
MZ B cells (Cariappa, A., K. Georgopoulos, and S. Pillai,
unpublished results), indicating that Aiolos is not directly
required for MZ B cell development. Although NF-
kBp50–containing complexes are known to be induced
when splenic B cells are triggered to proliferate with anti-
IgM (26), MZ B cells do not proliferate in response to anti-
gen receptor ligation (4), and it is unclear whether the
BCR is required to induce NF-kB during MZ B cell gen-
eration. Candidate signaling molecules on B cells that may
be involved in MZ B cell development are the TNF recep-
tor family members, transmembrane activator and calcium
modulator and cyclophilin ligand interactor (TACI) and B
Figure 4. NF-kBp50 must be expressed in developing lymphocytes for
MZ B cell generation. Rag-22/2 mice were reconstituted with fetal liver
from p502/2/p652/2 mice, and bone marrow from Rag-22/2 mice. Re-
constitution results in clearly identifiable IgMhiIgDlo, IgMhiIgDhi, and IgDhi
IgMlo subpopulations (top panels). In the IgMhiIgDlo fraction, CD21hi
cells were markedly reduced in the p502/2/p652/2 chimeras (bottom
panels). Six separate p502/2/p652/2 chimeric mice were analyzed in
these studies. The results shown are representative. WT, wild-type.
Figure 5. Absolute numbers of splenic B cells in wild-type (WT) and
mutant mice. (a) Absolute numbers of newly formed, follicular, and MZ
B cells in wild-type, p502/2, c-Rel2/2, and Rag-22/2 mice reconstituted
with mixtures including wild-type, p652/2, and p502/2/p652/2 fetal
liver cells, respectively, in combination with Rag-22/2 bone marrow
cells. (b) Absolute numbers of MZ B cells in the above mice depicted us-
ing an expanded scale.1181 Cariappa et al.
cell maturation antigen (BCMA) (27), which are triggered
by B lymphocyte stimulator (BlyS)/B cell activator belong-
ing to the TNF family (BAFF) (28, 29). BlyS/BAFF is
made in membrane-bound and cleaved/secreted forms by
macrophages, dendritic cells, and T cells. Transgenic over-
expression of BAFF led to an increase in MZ B cell gener-
ation (30). It is conceivable that NF-kBp50 may be in-
duced downstream of TACI and BCMA during the
generation of MZ B cells.
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